N/A
N=47
Online Peer Networked Collaborative Learning for Managing Depressive Symptoms
Depression
Bottom Line
View on ClinicalTrials.gov: NCT02841787 ↗Enrolled (actual)
47
Serious AEs
0.0%
Results posted
Oct 2018
Primary outcome: Primary: Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module — -5.4; -4.8; -1.1 units on a scale — p=< .001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- iCBT for late life depression (Behavioral)
- Age
- Older Adult · 65+ yrs
- Sex
- All
- Sponsor
- Northwestern University
- Primary completion
- Aug 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module |
-5.4; -4.8; -1.1 | < .001 sig |
| PRIMARY Mean Number of Sessions Across the 8-week Trial |
45.6; 49.1 | — |
| PRIMARY System Usability Scale (SUS) |
68.75; 60.5 | — |
| PRIMARY Average Coaching Time Per Participant by Group |
134.33; 92.43 | 0.003 sig |
Summary
The goal of this field trial is to tailor and test a web-based intervention in adults 65 years of age or older. Two versions of the web-based intervention have been created and will be tested--one with an online social network and one without an online social network. The purpose of this study is to: pilot a novel intervention, examine methods to improve adherence to web-based interventions (e.g., peer network); collect data on feasibility, acceptability, and efficacy of an web-based intervention for late life depression; and ultimately, to overcome the numerous barriers to treating depression in later life.
Eligibility Criteria
Inclusion Criteria
- Has elevated depressive symptoms
- Has a telephone, e-mail account, computer, and broadband access to the Internet.
- Has basic internet skills and is able to access the internet independently
- Is able to speak and read English.
- Is at least 65 years of age.
- Is able to give informed consent.
Exclusion Criteria
- Has hearing or voice impairment that would prevent participation in psychotherapy
- Has visual impairment that would prevent completion of assessment materials.
- Is diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current substance abuse, or other diagnosis for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous.
- Is currently receiving individual psychotherapy or planning to receive psychotherapy during the 8-week treatment phase of the study
- Is planning to be out of town or unavailable for an extended period of time during the study without access to the Internet
- Exhibits severe suicidality, including ideation, plan, and intent.
- Has initiated treatment with an antidepressant in past 14 days. Once patients have been on a stable dose for 14 days and do not have an appointment with a physician or psychiatrist to change this dose, the patient will be eligible based on this criterion.
Data sourced from ClinicalTrials.gov (NCT02841787). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.